Acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) following treatment for ovarian cancer

被引：0
|
作者：
Gupta, B. [1 ]
Sait, S. N. [1 ]
Block, A. W. [1 ]
Ford, L. A. [1 ]
Moysich, K. B. [1 ]
Baer, M. R. [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
17506
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Myelodysplastic Syndrome and Acute Myeloid Leukemia Incidence Following Primary Breast Cancer Treatment
    Kaplan, H. G.
    Malmgren, J. A.
    Atwood, M. K.
    CANCER RESEARCH, 2009, 69 (24) : 619S - 619S
  • [22] MORPHOLOGY OF T(8-21) ACUTE MYELOID-LEUKEMIA MYELODYSPLASTIC SYNDROME (AML/MDS)
    HUTCHISON, R
    LAWRENCE, D
    MACCALLUM, J
    VARNEY, J
    DEHORITY, D
    WURSTERHILL, D
    BLOOMFIELD, C
    DAVEY, F
    LABORATORY INVESTIGATION, 1991, 64 (01) : A74 - A74
  • [23] Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia
    Feldman, EJ
    Seiter, KP
    Ahmed, T
    Baskind, P
    Arlin, ZA
    LEUKEMIA, 1996, 10 (01) : 40 - 42
  • [24] Transformation of myelodysplastic syndrome (MDS) to hypocellular Acute Myeloid Leukemia (AML) post renal transplant.
    Hasni, K
    Gunnala, V
    Shah, M
    Hoang, T
    Kung, SC
    Brodsky, I
    Kumar, MA
    Heifets, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 923A - 923A
  • [25] Detection of FLT3 gene mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)
    Andrei, A.
    Crisan, D.
    Meng, X.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (05): : 639 - 639
  • [26] Treatment-related myelodysplastic syndrome (t-MDS)/acute myeloid leukemia (AML) in children with cancer: A single-center experience
    Tragiannidis, Athanasios
    Gombakis, Nikolaos
    Papageorgiou, Maria
    Hatzipantelis, Emmanuel
    Papageorgiou, Theodotis
    Hatzistilianou, Maria
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2016, 29 (04) : 729 - 730
  • [27] Combinations of topotecan and liposomal daunorubicin (Daunoxome) in refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Giles, FJ
    Kantarjian, HM
    Cortes, JE
    Koller, C
    Thomas, D
    O'Brien, SM
    Estey, E
    Beran, M
    BLOOD, 1999, 94 (10) : 230B - 230B
  • [28] Treatment Results of Intensive Chemotherapy for Higher-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia Related to MDS (MDS-AML)
    Kyo, Taiichi
    Yoshida, Noriaki
    Kyo, Kouhei
    Okatani, Takeshi
    Itagaki, Mitsuhiro
    Yuasa, Hiromi
    Iwato, Koji
    Asaoku, Hideki
    Katayama, Yuuta
    BLOOD, 2010, 116 (21) : 1209 - 1210
  • [29] WHO classification af acute myeloid leukaemia (AML) and the myelodysplastic syndrome (MDS)
    Haferlach, T
    Schoch, C
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (09) : 447 - 450
  • [30] Plasma DNA as a source of diagnostic and monitoring material in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
    Rogers, A
    Joe, Y
    Manshouri, T
    Giles, F
    Estey, EH
    Freireich, EJ
    Keating, MJ
    Kantarjian, HM
    Albitar, M
    BLOOD, 2001, 98 (11) : 576A - 576A
12345